Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Catalyst Pharmaceutical Partners, Inc. (CPRX)  
$23.41 0.02 (0.09%) as of 4:30 Fri 11/28


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 103,650,000
Market Cap: 2.43(B)
Last Volume: 527,443 Avg Vol: 1,550,529
52 Week Range: $19.13 - $26.31
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  1161
Guru Rank Value     : 0
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s primary product, Firdapse®, is used for the treatment of adult patients (ages 17 and above) with Lambert-Eaton, Myasthenic Syndrome, a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs. Co. has developed its vigabatrin (CPP-109) as a generic version of Sabril®. Co. has an agreement with Endo International plc's subsidiary, Endo Ventures Limited, for the development and commercialization of generic Sabril® tablets through Endo's U.S. Generic Pharmaceuticals segment, Par Pharmaceutical.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 120,000 487,894 1,170,292 2,766,303
Total Sell Value $2,504,200 $11,156,228 $26,806,422 $58,728,887
Total People Sold 1 6 8 10
Total Sell Transactions 4 11 19 45
End Date 2025-08-31 2025-05-30 2024-11-29 2023-11-30

   
Records found: 407
  Page 1 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Del Carmen Jeffrey Chief Commercial Officer   •       –      –    2025-11-26 4 S $23.33 $256,244 D/D (10,983) 3,962     -
   Del Carmen Jeffrey Chief Commercial Officer   •       –      –    2025-11-26 4 OE $4.21 $46,238 D/D 10,983 14,945     -
   Denkhaus Donald A Director   –       •      –    2025-11-21 4 OE $0.00 $0 D/D 947 496,026     -
   Miller Steve Chief Op. & Scientific Officer   •       –      –    2025-11-21 4 OE $0.00 $0 D/D 8,267 1,067,930     -
   Thompson Tamar Director   –       •      –    2025-11-21 4 OE $0.00 $0 D/D 947 2,360     -
   Sundaram Preethi Chief Strategy Officer   •       –      –    2025-11-21 4 D $0.00 $0 D/D (1,364) 45,320     -
   Sundaram Preethi Chief Strategy Officer   •       –      –    2025-11-21 4 OE $0.00 $0 D/D 5,603 46,684     -
   Harper Molly Director   –       •      –    2025-11-21 4 OE $0.00 $0 D/D 947 7,693     -
   Daly Richard J President and CEO   •       •      –    2025-11-21 4 D $0.00 $0 D/D (7,872) 238,928     -
   Daly Richard J President and CEO   •       •      –    2025-11-21 4 OE $0.00 $0 D/D 20,006 246,800     -
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2025-11-21 4 D $0.00 $0 D/D (2,030) 234,170     -
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2025-11-21 4 OE $0.00 $0 D/D 5,161 236,200     -
   Del Carmen Jeffrey Chief Commercial Officer   •       –      –    2025-11-21 4 D $0.00 $0 D/D (1,641) 3,962     -
   Del Carmen Jeffrey Chief Commercial Officer   •       –      –    2025-11-21 4 OE $0.00 $0 D/D 5,603 5,603     -
   Kalb Michael Wayne Executive Vice President & CFO   •       –      –    2025-11-21 4 D $0.00 $0 D/D (2,485) 8,606     -
   Kalb Michael Wayne Executive Vice President & CFO   •       –      –    2025-11-21 4 OE $0.00 $0 D/D 6,894 11,091     -
   Tierney David S Director   –       •      –    2025-11-21 4 OE $0.00 $0 D/D 947 380,567     -
   Mcenany Patrick J Chairman of Board of Directors   –       •      –    2025-11-21 4 OE $0.00 $0 D/D 1,775 4,283,477     -
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2025-11-12 4 S $22.70 $908,000 D/D (40,000) 231,039 -3%     
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2025-09-08 4 S $20.30 $609,000 D/D (30,000) 271,039 -17%     
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2025-09-08 4 OE $2.24 $251,944 D/D 112,475 301,039     -
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2025-09-04 4 S $19.52 $585,600 D/D (30,000) 188,564 -18%     
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2025-09-04 4 OE $2.24 $67,200 D/D 30,000 218,564     -
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2025-09-03 4 S $20.08 $401,600 D/D (20,000) 188,564 -18%     
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2025-09-03 4 OE $2.24 $44,800 D/D 20,000 208,564     -
  407 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us